
COVID-19 and why tackling the silent crisis of drug-resistant infections matters more than ever – by Manica Balasegaram
more
The antibiotics marketplace collapse: It’s just math, and it’s a solvable equation – by Ryan Cirz and Kevin Krause
more
Diagnostics to safeguard new and current antibiotics for gonorrhoea – by Cassandra Kelly-Cirino and Cecilia Ferreyra
more
On fireworks and finding ways to address drug-resistance in low- and middle-income countries – by Ramanan Laxminarayan
more
Bringing antimicrobial research and development to Africa – the time is now – by Greg Basarab and Kelly Chibale
more
Talking about the ‘antibiotic apocalypse’ won’t encourage public action – here’s why – by Tim Jinks
more
A new cephalosporin has been approved – by Ursula Theuretzbacher
more